LIVERFASt select is a risk stratification tool for fatty liver disease that utilizes a combination of basic blood biomarkers and algorithm technology.
© Copyright Fibronostics. All Rights Reserved
Fibronostics is a healthcare technology company focused on transforming non-invasive solutions for early disease intervention.